Approval is specific.
FDA approval applies to a product, route, population, and indication. An approved molecule does not make a compounded version or a research vial FDA approved.
A CLEARER PATH THROUGH PEPTIDE SCIENCE
Find your bearings.
Follow the evidence.
Explore what peptides are used for, where the evidence stands, and what the risks mean. One searchable reference, grounded in your complete peptide guide.
Explore the glossary ↓Go to the literature ↗38Peptide profiles
48Source references
USFDA context
i
Evidence before enthusiasm. Approved indications and marketed uses are different. This reference supports clinical conversations; it does not recommend a treatment or dose. Content reviewed October 16, 2026.
01 / THE GLOSSARY
A place for every peptide.
Search the full guide by name, condition, benefit, risk, or route.
Five peptides verified in JRE discussions. This is a discussion shortlist, not a measured frequency ranking or evidence of clinical effectiveness.
No profiles match those filters.
Try a broader term or reset your filters to explore all 38 profiles.
Structure thumbnails link to their PubChem records. Some entries describe a family, mixture, or variable preparation; representative structures are labeled, and unavailable structures are identified. Images are identifiers, not evidence of safety or effectiveness.
FDA status refers to specific products and indications. Historical approvals, cosmetics, and supplements have their own labels. Profile details explain the distinctions.
02 / GO TO THE SOURCE
Curiosity deserves
a closer look.
Build a focused search of the biomedical literature. Your query opens directly on PubMed, with the newest publications first.
A study being indexed on PubMed does not establish benefit, FDA approval, or suitability for an individual.
03 / A BETTER FRAME OF REFERENCE
Read beyond the headline.
Three distinctions to keep in view as you explore.
Mechanism is a beginning.
A change in hormones, a cell experiment, or an animal study may justify research. It does not establish a meaningful benefit or long-term safety in people.
Unknown is not low risk.
Small studies can miss uncommon or delayed harms. For experimental products, purity, strength, sterility, and interactions may be uncertain.
About this reference and its sources +
Peptide Compass adapts all 38 profiles from revision 2 of your Guide to Peptide Uses Benefits and Risks, including the supplied spreadsheet. The narrative guide contains 48 references. Evidence labels are editorial summaries, not formal GRADE assessments. Benefits and approved populations differ by formulation; current labels should be checked at the point of care.
Compounding eligibility is separate from FDA product approval and may change. The guide does not assign blanket legal compounding eligibility. No dosing, reconstitution, or supplier recommendations are provided. The original Bolt project required sign-in and was not incorporated.
The JRE filter identifies BPC-157, TB-500, ipamorelin, CJC-1295, and Melanotan II from verified discussions; no complete frequency ranking was established.